|
March 3, 2000
News this month
Want to lower your risk? Try raising your levels of good cholesterol
For more than a decade, most clinical trials to prevent heart
disease have focused on the impact of medications to lower low-density
lipoproteins (LDLs), the so-called bad cholesterol. In an effort
to lower their risk, millions of Americans have successfully reduced
their LDL levels with the help of a group of drugs called statins.
Focusing attention on the "other" cholesterol
The importance of so-called good cholesterol, high-density lipoproteins
(HDLs), and triglycerides in the blood has taken a back seat. Now
dramatic results from a large clinical trial have renewed interest
in the role of other lipids (fat-like substances) in the blood.
This is the first trial to demonstrate
a reduced risk of cardiac events from intervention that raised HDL
levels but did not reduce LDLs.
The study, published last summer, suggests people might benefit
from increasing levels of HDLs. The Veterans Affairs High-Density
Lipoprotein Cholesterol Intervention Trial (VA-HIT), published in
the New England Journal of Medicine in August, found that
the generic medicine gemfibrozil slightly increased good cholesterol
(7.5%) and significantly lowered triglycerides (24.5%), reducing
the risk of a heart attack or death from heart disease by 22 percent
and cutting the incidence of stroke by 29 percent. This is the first
trial to demonstrate a reduced risk of cardiac events from intervention
that raised HDL levels but did not reduce LDLs.
Good cholesterol fights plaque
Doctors often recommend cholesterol-lowering drugs for people whose
LDL is above recommended levels. However, about one-quarter of the
12 to 13 million people in the U.S. with heart disease have normal
amounts of LDL, while their HDL, the blood component that keeps
arteries clean, is low. The two types of cholesterol have opposite
effects on the progression of heart disease:
- LDL tends to build up plaque in arteries
- HDL tends to prevent or reverse buildups.
The VA study
"Gemfibrozil works. Its cheap. Its well-tolerated,"
said Dr. Hanna Rubins, chief of general internal medicine at the
Minneapolis Veterans Medical Center and lead author of the study,
which followed about 2,500 men at 20 veterans hospitals around
the country.
In the study, 2,531 middle-aged men with a history of coronary
artery disease were enrolled in the study between September 1991
and December 1993. Of these, 1,264 men were randomly assigned to
take gemfibrozil while 1,267 others got placebos. At the start,
average LDL levels were 111 mg/dL, close to ideal, while HDL was
31.5 mg/dL, well below what is considered the healthy level of 45
or higher. Gemfibrozil was chosen because it was felt to be most
likely to raise HDL cholesterol and lower triglycerides without
any marked effect on LDL cholesterol.
Study findings
The treatment raised HDL an average of 7.5 percent while LDL levels
remained unchanged. After five years, 17 percent of patients taking
gemfibrozil had died or suffered heart attacks compared with 21
percent in the control group.
Gemfibrozil therapy resulted in a significant reduction in the
risk of major cardiovascular events in heart disease patients whose
primary lipid abnormality is a low HDL cholesterol level. The findings
suggest the rate of heart attack or death from heart disease is
reduced by raising HDL cholesterol levels and lowering triglycerides,
even if LDL levels remain unchanged. 
Calculating cholesterol
Cholesterol guidelines can be confusing. Suppose you have
total cholesterol of 280 mg/dL (high risk), but an HDL cholesterol
reading of 70 (low risk). Are you at high risk or low risk
for developing coronary artery disease? Many physicians calculate
a risk ratio by dividing the total cholesterol by the total
HDL. Despite a high, total cholesterol of 280 mg/dL, the patient
is actually at lower than average risk with an HDL level of
70 mg/dL. The risk ratio is only 4 (280 divided by 70).
- 3.5 or below is ideal
- 4.5 is average risk
- 5.1 or higher is potentially dangerous
The use of this ratio may predict coronary
artery disease more accurately than total cholesterol levels.
|
Physician Referral Online
A free and confidential service
of Yale-New Haven Hospital.
Physician Referral Online
Using your own criteria, you can request information from a database
of 900 area physicians who have registered to participate.
Request an appointment
We would be happy to assist you in scheduling an appointment with
a member of the hospital's medical staff. Use the link above or
call:
203-688-2000
or toll free
1-888-700-6543
to talk with a referral coordinator.
|
|
The right kind of cholesterol can be
good for you
The VA-HIT trial is important for several reasons. Despite many
studies that link high levels of bad cholesterol (LDL) to increased
risk of coronary heart disease (CHD), it has never been clear
whether raising the levels of good cholesterol (HDL) would also
reduce risk. The VA-HIT is the first trial to demonstrate a significant
reduction in risk from a medication that has no apparent effect
on the bad cholesterol (LDL), but does raise good cholesterol
(HDL).
"…low HDL levels [good
cholesterol] are an even more significant predictor of heart attack
and death from heart disease than high LDL levels [bad cholesterol]."
And the reduction in risk is dramatic. A 7.5 percent increase
in good cholesterol (HDL) resulted in a 22 percent decrease
in risk of heart attack or death from heart disease.
Good cholesterol more important than bad?
We believe low HDL levels are an even more significant predictor
of heart attack and death from heart disease than high LDL levels.
After looking at existing data comparing populations with heart
disease with those without, we note a stronger correlation between
low levels of good cholesterol and heart disease than between
higher levels of bad cholesterol and disease.
"…for every percentage
point were able to raise HDLs, we reduce risk by three percentage
points."
From early studies, we also note a one-to-one relationship between
lowering LDL levels and reducing risk, that is, if we lower
LDL by 1 percent we also reduce risk by 1 percent. Raising good
cholesterol results in a three to one risk ratio: for every percentage
point were able to raise HDLs, we reduce risk by three percentage
points. Clearly, raising good cholesterol is important.
Takes longer to benefit from increasing good cholesterol
The benefit, however, takes longer. In intervention trials using
statin drugs to lower bad cholesterol, benefits were apparent
as early as six months after treatment began. Raising good cholesterol
levels resulted in benefits after two years in the VA-HIT study.
How does good cholesterol work?
HDL acts like a scavenger molecule, grabbing LDL from the walls
of blood vessels and returning it to the liver. High HDL levels,
above 45, appear to protect arteries from narrowing. According
to some studies, levels below 35 are highly predictive of death
from heart disease.
Why is the bad so bad?
LDL is the primary villain in the cholesterol story because when
a person has too much LDL circulating in the blood, it can slowly
build up within the walls of the arteries. Together with other
substances it can then form plaque, a thick, hard deposit that
can clog those arteries, or rupture and cause a blood clot.
Treating heart disease: the state of the art
Over the last decade there have been a series of important studies
that have added to what we know about heart disease, but these
have all focused either on lowering total cholesterol levels or
lowering bad cholesterol. Lowering both of these has been demonstrated
to lower the risk of heart attack and death from heart disease.
Where are we now? Researchers such as those in the VA-HIT study
are now looking beyond total cholesterol and LDL to determine
the role additional lipids play in heart disease such as good
cholesterol or HDL, triglycerides and even more esoteric substances
such as lipoprotein (a), Apolipoprotein A-1 and B as well as other
substances such as homocysteine, an amino acid found in the blood.
Our understanding of these blood components is in its infancy,
but as we learn more, new medications will be developed to reduce
risk more effectively than we can do now.
Many of the same behaviors that reduce your risk of heart disease
also raise your level of good cholesterol:
- aerobic exercise
- healthy weight
- stopping smoking
- ERT
- moderate alcohol consumption
What should you do?
When you look at lab results with your physician, look beyond
total cholesterol numbers to determine your LDL and HDL levels.
Information located on Yale-New Haven Hospitals cardiac
services site lists recommended
LDL and HDL levels based on your total risk factor profile.
Lifestyle changes help
Many of the same behaviors that reduce your risk of heart disease
also raise your good cholesterol levels, including aerobic exercise,
maintaining a healthy weight, stopping smoking, estrogen replacement
therapy for postmenopausal women and moderate alcohol consumption.
If a healthy lifestyle doesnt appreciably change your lipid
profile, talk with your physician about what medication therapy
might be appropriate for you. 
Dr. Swirsky, FACC, is a cardiologist and a partner with The
Cardiology Group practicing in New Haven and Branford. He is an
attending physician at Yale-New Haven Hospital and an assistant
clinical professor of medicine at the Yale School of Medicine.
|